A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects
NCT07476157
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
70
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Heart Failure
Interventions
DRUG:
AD-118, AD-1181
Sponsor
Addpharma Inc.